Cargando…

Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization

The objective of this study was to evaluate physicochemical equivalence between brand (i.e., Ferrlecit) and generic sodium ferric gluconate (SFG) in sucrose injection by conducting a series of comparative in vitro characterizations using advanced analytical techniques. The elemental iron and carbon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Dajun, Rouse, Rodney, Patel, Vikram, Wu, Yong, Zheng, Jiwen, Karmakar, Alokita, Patri, Anil K., Chitranshi, Priyanka, Keire, David, Ma, Jia, Jiang, Wenlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791112/ https://www.ncbi.nlm.nih.gov/pubmed/29303999 http://dx.doi.org/10.3390/nano8010025

Ejemplares similares

Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake
por: Wu, Min, et al.
Publicado: (2017)

Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Biodistribution after Intravenous Dosing in Rats
por: Beekman, Christopher R., et al.
Publicado: (2017)

Rhabdomyolysis after Intravenous Ferric Gluconate: A Case Report
por: Botti, Mara, et al.
Publicado: (2022)

An analytical method for Fe(II) and Fe(III) determination in pharmaceutical grade iron sucrose complex and sodium ferric gluconate complex
por: Merli, Daniele, et al.
Publicado: (2012)

Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study
por: Rosati, Alberto, et al.
Publicado: (2022)

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: reduction of erythropoietin dose in 4 years of follow-up
por: Lacquaniti, Antonio, et al.
Publicado: (2020)

Cost-Minimization Analysis Favours Intravenous Ferric Carboxymaltose over Ferric Sucrose for the Ambulatory Treatment of Severe Iron Deficiency
por: Calvet, Xavier, et al.
Publicado: (2012)

Brand and generic medications: Are they interchangeable?
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2008)

Prescription writing: Generic or brand?
por: Andrade, Chittaranjan, et al.
Publicado: (2017)

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis
por: Lacquaniti, Antonio, et al.
Publicado: (2023)

Bioequivalence of generic and branded amoxicillin capsules in healthy human volunteers
por: Pathak, Priyanka, et al.
Publicado: (2017)

Induction of tumours in mice and rats with ferric sodium gluconate and iron dextran glycerol glycoside.
por: Carter, R. L., et al.
Publicado: (1968)

Physicochemical characterization of ferric pyrophosphate citrate
por: Gupta, Ajay, et al.
Publicado: (2018)

Determination of Non-Transferrin Bound Iron, Transferrin Bound Iron, Drug Bound Iron and Total Iron in Serum in a Rats after IV Administration of Sodium Ferric Gluconate Complex by Simple Ultrafiltration Inductively Coupled Plasma Mass Spectrometric Detection
por: Matta, Murali K., et al.
Publicado: (2018)

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
por: Desai, Rishi J, et al.
Publicado: (2018)

Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
por: Basha, Ahmad, et al.
Publicado: (2021)

Safety and efficacy of generic drugs with respect to brand formulation
por: Gallelli, Luca, et al.
Publicado: (2013)

Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
por: Wadhwani, Meenakshi, et al.
Publicado: (2016)

Comparison of Ferric Sodium EDTA in Combination with Vitamin C, Folic Acid, Copper Gluconate, Zinc Gluconate, and Selenomethionine as Therapeutic Option for Chronic Kidney Disease Patients with Improvement in Inflammatory Status
por: Giliberti, Antonella, et al.
Publicado: (2022)

Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
por: Singh, A. K., et al.
Publicado: (2011)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015)

Assessment of the equivalence of a generic to a branded femoral stem
por: Hothi, H., et al.
Publicado: (2017)

Potential Clinical and Economic Impact of Switching Branded Medications to Generics
por: Straka, Robert J., et al.
Publicado: (2017)

HPLC-Based Analysis of Impurities in Sapropterin Branded and Generic Tablets
por: Scudellaro, Emanuela, et al.
Publicado: (2020)

Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020)

Pharmacist Intervention in Safe and Effective Conversion of Brand to Generic Drugs
por: Summers, Kent H.
Publicado: (2005)

A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose
por: Pollock, Richard F., et al.
Publicado: (2022)

A comparative evaluation of price and quality of some branded versus branded–generic medicines of the same manufacturer in India
por: Singal, G.L., et al.
Publicado: (2011)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
por: Hofman, Jesse M. G., et al.
Publicado: (2018)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014)

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)

Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization
por: Alderfer, Justine, et al.
Publicado: (2022)

Analyzing generic and branded substitution patterns in the Netherlands using prescription data
por: Pechlivanoglou, Petros, et al.
Publicado: (2011)

Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates
por: Olszynski, Wojciech P., et al.
Publicado: (2014)

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
por: Zhao, Xiao-Ying, et al.
Publicado: (2013)

Recurrence of atrial fibrillation after switching from brand to generic atenolol
por: Gallelli, Luca, et al.
Publicado: (2015)

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017)

Elemental impurities analysis in name-brand and generic omeprazole drug samples
por: Pinheiro, Fernanda C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_us0g2aofn79aeb4jpnd96ifmt3